May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Effect of Exogenous Mesenchymal Stem Cells on Wound Healing Following Corneal Alkali Burn
Author Affiliations & Notes
  • Y. Juan
    Ophthalmology, Chungang Univ. Yongsan Hospital, Seoul, Republic of Korea
  • J. Kim
    Ophthalmology, Chungang Univ. Yongsan Hospital, Seoul, Republic of Korea
  • I. Jang
    Ophthalmology, Chungang Univ. Yongsan Hospital, Seoul, Republic of Korea
  • J. Han
    Ophthalmology, Chungang Univ. Yongsan Hospital, Seoul, Republic of Korea
  • J. Shin
    Ophthalmology, Chungang Univ. Yongsan Hospital, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  Y. Juan, None; J. Kim, None; I. Jang, None; J. Han, None; J. Shin, None.
  • Footnotes
    Support  21C frontier research program (code: stem cell 13), ministry of science and technology, Korea
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 891. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Juan, J. Kim, I. Jang, J. Han, J. Shin; Effect of Exogenous Mesenchymal Stem Cells on Wound Healing Following Corneal Alkali Burn . Invest. Ophthalmol. Vis. Sci. 2003;44(13):891.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate whether exogenous mesenchymal stem cells (MSC) involve in wound healing after corneal alkali burn in normal and suppressed bone marrow condition of rabbit model. Methods: A standardized 6mm diameter corneal and limbal alkali wound was induced in one eye of each of 80 rabbits. CM-DiI prelabeled rabbit MSC were cultured to 2nd generation before application. We divided rabbits into two different conditions: (1) Normal groups--group A: intravenous injection of 1×107 MSC; group B: local subconjunctival injuction of 1×107 MSC; group C: temporary amniotic membrane patch (TAMP) with 1×107 MSC seeded on stroma side; group D: TAMP; group E: control. (2) Bone marrow suppressed groups (treated with cyclophosphamide)--group F: intravenous injection of 1×107 MSC; group G: TAMP with 1×107 MSC seeded on stroma side; group H: control. The clinical outcomes and the presence of exogenous CM-DiI-MSC in peripheral blood, bone marrow and wounded cornea were evaluated. Results: (1) The infiltration of exogenous MSC into wounded corneal three layers occurred on the second day after application. (2) Under normal condition: the best clinical outcomes with stabilized ocular surface was revealed in group A, in which neovascularization appeared in wounded limbal cornea (3 days post injury) where the massive infiltration (89.0±25.8) of typical spindle-shaped MSC was found. The next is group B showing later onset neovascularization (4-5 days post injury) with less corneal infiltrated MSC (58.2±14.3) and moderate corneal opacification (grade 1.5). (3) Under suppressed condition, corneal wound healing was delayed with less difference of final outcomes among these groups. Conclusions: Exogenously applied MSC may enhance corneal wound healing by potentially being differentiated into corneal cells. Differentiation of these cells may need to be supported by other types of hematopoietic stem cells.

Keywords: cornea: clinical science • wound healing • neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×